Immune Evasion and Resistance in Cancer Progression: Overcoming Checkpoint Inhibition Challenges with Personalized Immunotherapy Guided by PD-L1 Expression. Journal of Analytical Oncology, [S. l.], v. 14, p. 49–61, 2025. DOI: 10.30683/1927-7229.2025.14.09. Disponível em: https://www.neoplasiaresearch.com/index.php/jao/article/view/887. Acesso em: 1 nov. 2025.